136 related articles for article (PubMed ID: 1692574)
1. Nucleolar organizer regions in fibrohistiocytic tumors of the skin.
Merot Y; Durgniat AC; Frenk E
J Cutan Pathol; 1990 Apr; 17(2):122-6. PubMed ID: 1692574
[TBL] [Abstract][Full Text] [Related]
2. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
Oshiro Y; Fukuda T; Tsuneyoshi M
Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
[TBL] [Abstract][Full Text] [Related]
3. Flow-cytometric DNA analysis in cutaneous fibrohistiocytic tumors.
Okita H; Ohtsuka T; Yamazaki S
Dermatology; 2003; 207(4):357-61. PubMed ID: 14657626
[TBL] [Abstract][Full Text] [Related]
4. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
[TBL] [Abstract][Full Text] [Related]
5. [Fibrohistiocytic skin tumors].
Hügel H
J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
[TBL] [Abstract][Full Text] [Related]
6. S100A6 expression in fibrohistiocytic lesions.
Fullen DR; Reed JA; Finnerty B; McNutt NS
J Cutan Pathol; 2001 May; 28(5):229-34. PubMed ID: 11401666
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar organizer regions of lymphomas in Korea.
Kim I; Park SH; Paik SY
J Korean Med Sci; 1988 Sep; 3(3):99-105. PubMed ID: 2477040
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
9. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
Fallowfield ME; Cook MG
Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
Franchi A; Santucci M
Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
[TBL] [Abstract][Full Text] [Related]
11. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
13. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
14. [A biological and morphological study of ovoid and spindle cells in malignant fibrous histiocytomas].
Kushimoto T; Yokozumi K; Ogihara Y; Yatani R; Imahara T
Nihon Seikeigeka Gakkai Zasshi; 1993 Sep; 67(9):836-46. PubMed ID: 8409644
[TBL] [Abstract][Full Text] [Related]
15. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
[TBL] [Abstract][Full Text] [Related]
16. [The nucleolus organizer region in benign and malignant melanocyte lesions of the skin: a quantitative study].
Sementa AR; Gambini C; Borgiani L; Palladino M; Corso M; Canepa M
Pathologica; 1989; 81(1073):231-7. PubMed ID: 2484303
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA analysis of malignant fibrous histiocytoma and related fibrohistiocytic tumors.
Radio SJ; Wooldridge TN; Linder J
Hum Pathol; 1988 Jan; 19(1):74-7. PubMed ID: 2826327
[TBL] [Abstract][Full Text] [Related]
18. Tissue cultures of benign and malignant fibrous histiocytomas: SEM observations.
Oku T; Takigawa M; Fukamizu H; Yamada M
J Cutan Pathol; 1984 Dec; 11(6):534-40. PubMed ID: 6097601
[TBL] [Abstract][Full Text] [Related]
19. Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplasms.
Costa MJ; McGlothlen L; Pierce M; Munn R; Vogt PJ
Arch Pathol Lab Med; 1995 Nov; 119(11):1065-71. PubMed ID: 7487409
[TBL] [Abstract][Full Text] [Related]
20. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
Kutzner H
J Am Acad Dermatol; 1993 Apr; 28(4):613-7. PubMed ID: 7681857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]